tert-Butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate

Catalog No. :
ACQUDY698
CAS No. :
1202864-54-7
Molecular Formula :
C11H11BrClN3O2
Molecular Weight :
332.58

IUPAC Name:tert-butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate

tert-Butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$231.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
IUPAC Nametert-butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
MDL No.MFCD15144827
Molecular FormulaC11H11BrClN3O2
Molecular Weight332.58
SMILESCC(C)(C)OC(=O)N1C=C(Br)C2=C(Cl)N=CN=C12
InChI KeyMLKPVEXAHVARSD-UHFFFAOYSA-N
Synonymtert-Butyl 5-bromo-4-chloro-7H-pyrrolo-[2,3-d]pyrimidine-7-carboxylate | tert-Butyl 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate | tert-Butyl5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate | DTXSID30745376 | 9-Boc-7-bromo-6-chloro
CAS No.1202864-54-7
PubChem CID71306609

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQUDY698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQUDY698 route product structure diagram
    ACQUDY6981202864-54-7
Inquiry

2. ACQUDY698 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQUDY698 route product structure diagram
    ACQUDY6981202864-54-7
Inquiry

Comments (0)